Is Philip Morris Stock Overvalued?
If there is one industry that can be termed truly…
Buy
67
FNB Quote, Financials, Valuation and Earnings
Last price:
$15.56
Seasonality move
:
3.27%
Day range:
$15.66 - $16.01
52-week range:
$12.49 - $17.70
Dividend yield:
3.02%
P/E ratio:
14.61x
P/S ratio:
3.70x
P/B ratio:
0.92x
Volume:
4.9M
Avg. volume:
2.6M
1-year change:
19.52%
Market cap:
$5.7B
Revenue:
$1.6B
EPS (TTM):
$1.09
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.2B | $1.4B | $1.6B | |
| Revenue Growth (YoY) | 0.25% | 1.82% | 0.32% | 16.65% | 8.87% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $411M | $439M | $450M | $462M | $540M | |
| Other Inc / (Exp) | $33M | $39M | $37M | $35M | -$40M | |
| Operating Expenses | $425M | $435M | $460M | $431M | $558M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $471M | $343M | $503M | $553M | $584M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $84M | $57M | $98M | $114M | $99M | |
| Net Income to Company | $387M | $286M | $405M | $439M | $485M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $387M | $286M | $405M | $439M | $485M | |
| Basic EPS (Cont. Ops) | $1.17 | $0.86 | $1.24 | $1.23 | $1.32 | |
| Diluted EPS (Cont. Ops) | $1.16 | $0.85 | $1.23 | $1.22 | $1.31 | |
| Weighted Average Basic Share | $324.9M | $323.4M | $319.8M | $350M | $360.7M | |
| Weighted Average Diluted Share | $326.1M | $325.5M | $323.5M | $354.1M | $362.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $801M | $551M | $601M | $718M | $1.2B | |
| Revenue (Reported) | $1.2B | $1.2B | $1.2B | $1.4B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $801M | $551M | $601M | $718M | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $311M | $320M | $380M | $407M | $412M | |
| Revenue Growth (YoY) | 0.32% | 2.89% | 18.75% | 7.11% | 1.23% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $104M | $113M | $115M | $127M | $142M | |
| Other Inc / (Exp) | $8M | $12M | $10M | $7M | $6M | |
| Operating Expenses | $103M | $115M | $116M | $132M | $146M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $100M | $138M | $173M | $164M | $140M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17M | $27M | $35M | $19M | $30M | |
| Net Income to Company | $83M | $111M | $138M | $145M | $110M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $83M | $111M | $138M | $145M | $110M | |
| Basic EPS (Cont. Ops) | $0.25 | $0.34 | $0.39 | $0.40 | $0.30 | |
| Diluted EPS (Cont. Ops) | $0.25 | $0.34 | $0.38 | $0.40 | $0.30 | |
| Weighted Average Basic Share | $323.4M | $319.5M | $350.9M | $360.8M | $361.3M | |
| Weighted Average Diluted Share | $325.7M | $322.9M | $354.7M | $361.8M | $362.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $146M | $162M | $219M | $351M | $400M | |
| Revenue (Reported) | $311M | $320M | $380M | $407M | $412M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $146M | $162M | $219M | $351M | $400M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.3B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $427M | $464M | $461M | $497M | $580M | |
| Other Inc / (Exp) | $40M | $34M | $35M | $30M | -$43M | |
| Operating Expenses | $436M | $462M | $440M | $502M | $598M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $374M | $465M | $500M | $701M | $512M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $65M | $87M | $101M | $128M | $106M | |
| Net Income to Company | $309M | $378M | $399M | $573M | $406M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $309M | $378M | $399M | $573M | $406M | |
| Basic EPS (Cont. Ops) | $0.93 | $1.15 | $1.14 | $1.58 | $1.09 | |
| Diluted EPS (Cont. Ops) | $0.93 | $1.15 | $1.13 | $1.57 | $1.09 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $626M | $578M | $613M | $1.2B | $1.4B | |
| Revenue (Reported) | $1.2B | $1.2B | $1.3B | $1.6B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $626M | $578M | $613M | $1.2B | $1.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $918M | $934M | $1B | $1.2B | $1.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $313M | $338M | $349M | $384M | $424M | |
| Other Inc / (Exp) | $32M | $27M | $25M | $20M | $17M | |
| Operating Expenses | $319M | $346M | $326M | $397M | $437M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $258M | $380M | $377M | $525M | $453M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $44M | $74M | $77M | $91M | $98M | |
| Net Income to Company | $214M | $306M | $300M | $434M | $355M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $214M | $306M | $300M | $434M | $355M | |
| Basic EPS (Cont. Ops) | $0.64 | $0.93 | $0.84 | $1.19 | $0.96 | |
| Diluted EPS (Cont. Ops) | $0.64 | $0.93 | $0.83 | $1.19 | $0.96 | |
| Weighted Average Basic Share | $970.9M | $960.1M | $1B | $1.1B | $1.1B | |
| Weighted Average Diluted Share | $976.9M | $970.9M | $1.1B | $1.1B | $1.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $430M | $457M | $469M | $974M | $1.2B | |
| Revenue (Reported) | $918M | $934M | $1B | $1.2B | $1.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $430M | $457M | $469M | $974M | $1.2B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $599M | $1.4B | $3.5B | $1.7B | $1.6B | |
| Short Term Investments | $3.3B | $3.5B | $3.4B | $3.3B | $3.3B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.3B | $5.3B | $7.4B | $5.5B | $5.4B | |
| Property Plant And Equipment | $333M | $332M | $345M | $432M | $461M | |
| Long-Term Investments | $6.6B | $6.3B | $6.9B | $7.4B | $7.2B | |
| Goodwill | $2.3B | $2.3B | $2.3B | $2.5B | $2.5B | |
| Other Intangibles | $67M | $54M | $42M | $89M | $69M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $34.6B | $37.4B | $39.5B | $43.7B | $46.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.3B | $1.3B | $1B | $930M | $1.9B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.1B | $1.7B | $1.4B | $1.2B | $2.4B | |
| Long-Term Debt | $1.4B | $1.2B | $812M | $1.2B | $2.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $29.7B | $32.4B | $34.4B | $38.1B | $40.1B | |
| Common Stock | $110M | $110M | $110M | $111M | $111M | |
| Other Common Equity Adj | -$65M | -$39M | -$62M | -$357M | -$235M | |
| Common Equity | $4.8B | $4.9B | $5B | $5.5B | $5.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.9B | $5B | $5.2B | $5.7B | $6.1B | |
| Total Liabilities and Equity | $34.6B | $37.4B | $39.5B | $43.7B | $46.2B | |
| Cash and Short Terms | $3.9B | $4.8B | $6.9B | $4.9B | $4.8B | |
| Total Debt | $3.7B | $2.5B | $1.8B | $2.1B | $4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $900M | $4.1B | $2.3B | $1.6B | $2.1B | |
| Short Term Investments | $3.1B | $3.2B | $3.4B | $3.1B | $3.5B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.5B | $7.8B | $6.2B | $5.3B | $6.3B | |
| Property Plant And Equipment | $335M | $342M | $421M | $460M | $505M | |
| Long-Term Investments | $6.1B | $6.4B | $7.2B | $7.1B | $7.3B | |
| Goodwill | $2.3B | $2.3B | $2.4B | $2.5B | $2.5B | |
| Other Intangibles | $57M | $45M | $52M | $74M | $56M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $37.4B | $39.4B | $42.6B | $45.5B | $48B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.4B | $1B | $930M | $1.7B | $930M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.8B | $1.4B | $1.3B | $2B | $1.4B | |
| Long-Term Debt | $1.5B | $1B | $1.2B | $2.1B | $2.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $32.5B | $34.3B | $37.2B | $39.6B | $41.7B | |
| Common Stock | $110M | $110M | $111M | $111M | $4M | |
| Other Common Equity Adj | -$26M | -$52M | -$378M | -$382M | -$154M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5B | $5.1B | $5.4B | $5.9B | $6.2B | |
| Total Liabilities and Equity | $37.4B | $39.4B | $42.6B | $45.5B | $48B | |
| Cash and Short Terms | $4B | $7.3B | $5.7B | $4.8B | $5.6B | |
| Total Debt | $2.9B | $2B | $2.1B | $3.7B | $3.6B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $387M | $286M | $405M | $439M | $485M | |
| Depreciation & Amoritzation | $45M | -$3M | $10M | $73M | $78M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$8M | $19M | $14M | -$42M | -$34M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $259M | $113M | $530M | $1.2B | $423M | |
| Capital Expenditures | $46M | $41M | $58M | $95M | $88M | |
| Cash Acquisitions | -- | -- | -- | $188M | -- | |
| Cash From Investing | -$1.1B | -$1.8B | -$153M | -$3.1B | -$2.3B | |
| Dividends Paid (Ex Special Dividend) | -$165M | -$165M | -$164M | -$179M | -$182M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $954M | $328M | $25M | $381M | $1.2B | |
| Long-Term Debt Repaid | -$239M | -$574M | -$438M | -$231M | -$352M | |
| Repurchase of Common Stock | -- | -$38M | -$43M | -$43M | -$36M | |
| Other Financing Activities | $12M | $17M | $16M | $11M | $8M | |
| Cash From Financing | $983M | $2.5B | $1.7B | $18M | $1.7B | |
| Beginning Cash (CF) | $488M | $599M | $1.4B | $3.5B | $1.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $111M | $784M | $2.1B | -$1.8B | -$98M | |
| Ending Cash (CF) | $599M | $1.4B | $3.5B | $1.7B | $1.6B | |
| Levered Free Cash Flow | $213M | $72M | $472M | $1.1B | $335M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $83M | $111M | $138M | $145M | $110M | |
| Depreciation & Amoritzation | -- | -$3M | $19M | $19M | $17M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $4M | $8M | -$15M | -$21M | $11M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $77M | $84M | $349M | $294M | -$14M | |
| Capital Expenditures | $13M | $11M | $28M | $11M | $32M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $233M | $240M | -$825M | -$771M | $31M | |
| Dividends Paid (Ex Special Dividend) | -$41M | -$41M | -$45M | -$45M | -$44M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $8M | $6M | $356M | $6M | $606M | |
| Long-Term Debt Repaid | -$241M | -$9M | -$9M | -$19M | -$108M | |
| Repurchase of Common Stock | -- | -$7M | -- | -- | -- | |
| Other Financing Activities | $3M | $4M | $3M | $3M | $4M | |
| Cash From Financing | -$341M | $842M | $723M | $410M | $181M | |
| Beginning Cash (CF) | $931M | $2.9B | $2B | $1.7B | $1.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$31M | $1.2B | $247M | -$67M | $198M | |
| Ending Cash (CF) | $900M | $4.1B | $2.3B | $1.6B | $2.1B | |
| Levered Free Cash Flow | $64M | $73M | $321M | $283M | -$46M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $309M | $378M | $399M | $573M | $406M | |
| Depreciation & Amoritzation | $17M | -$9M | $65M | $80M | $66M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $18M | $15M | -$19M | -$55M | -$8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $41M | $578M | $1.2B | $620M | $296M | |
| Capital Expenditures | $48M | $51M | $93M | $88M | $108M | |
| Cash Acquisitions | -- | -- | $75M | $113M | -- | |
| Cash From Investing | -$2.6B | $1.1B | -$3.2B | -$2.4B | -$1.8B | |
| Dividends Paid (Ex Special Dividend) | -$165M | -$164M | -$176M | -$180M | -$179M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $329M | $24M | $374M | $1.2B | $881M | |
| Long-Term Debt Repaid | -$273M | -$535M | -$434M | -$359M | -$336M | |
| Repurchase of Common Stock | -$25M | -$56M | -$43M | -$37M | -$113M | |
| Other Financing Activities | $19M | $15M | $11M | $9M | $13M | |
| Cash From Financing | $2.9B | $1.6B | $169M | $1.1B | $1.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $291M | $3.2B | -$1.8B | -$639M | $441M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$7M | $527M | $1.1B | $532M | $188M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $214M | $306M | $300M | $434M | $355M | |
| Depreciation & Amoritzation | $5M | -$1M | $54M | $61M | $49M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $18M | $14M | -$19M | -$32M | -$6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$81M | $384M | $1B | $443M | $316M | |
| Capital Expenditures | $33M | $43M | $78M | $71M | $91M | |
| Cash Acquisitions | -- | -- | $75M | -- | -- | |
| Cash From Investing | -$2.3B | $624M | -$2.4B | -$1.7B | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | -$124M | -$123M | -$135M | -$136M | -$133M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $322M | $18M | $367M | $1.2B | $877M | |
| Long-Term Debt Repaid | -$266M | -$227M | -$223M | -$351M | -$335M | |
| Repurchase of Common Stock | -$25M | -$43M | -$43M | -$37M | -$114M | |
| Other Financing Activities | $14M | $12M | $7M | $5M | $10M | |
| Cash From Financing | $2.7B | $1.7B | $155M | $1.2B | $1.4B | |
| Beginning Cash (CF) | $2.1B | $7B | $9.4B | $5.1B | $4.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $301M | $2.7B | -$1.2B | -$37M | $502M | |
| Ending Cash (CF) | $2.4B | $9.7B | $8.2B | $5.1B | $5.4B | |
| Levered Free Cash Flow | -$114M | $341M | $963M | $372M | $225M | |
Get FNB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FNB
Sector
P/E ratio
14.61x
12.07x
PEG ratio
--
0.36x
P/B ratio
0.92x
1.06x
Price / LTM sales
3.70x
2.59x
Growth Metrics
FNB
Sector
Revenue growth
1.23%
5.98%
Earnings growth
-25%
6.69%
Revenue (5-year growth)
5.4%
5.74%
Earnings forecast
$0.33
$0.57
Profitability
FNB
Sector
Profitability FY 2024
--
$170.7M
Return on invested capital
4.03%
5.27%
Return on assets
0.87%
0.98%
Return on equity
6.7%
9.4%
Earnings Date
Last Earnings Date
Jan
22
Next Earnings Date
Jan
22
Estimated Next Earnings Date
Apr
23
Balance Sheet
FNB
Sector
Total cash
$5.6B
$589.4M
Short term investments
$3.3B
$406.2M
Total assets
$46.2B
$4.4B
Long term debt
$3.6B
$257M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Quantum Stocks Should I Buy?
The last several years have seen a series of tech…
Will Sirius XM Be a 10-Bagger Stock?
Last year, Warren Buffett surprised practically everyone when he acquired…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
32
FTAI alert for Jan 22
FTAI Aviation [FTAI] is up 9.81% over the past day.
Sell
2
EDU alert for Jan 22
New Oriental Education & Technology Group [EDU] is down 1.13% over the past day.
Buy
51
GH alert for Jan 22
Guardant Health [GH] is up 4.5% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
